Filing Details

Accession Number:
0001193805-20-001005
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-12 08:02:57
Reporting Period:
2020-08-10
Accepted Time:
2020-08-12 08:02:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1368514 Adma Biologics Inc. ADMA Biological Products, (No Disgnostic Substances) (2836) 562590442
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1542517 S Adam Grossman C/O Adma Biologics, Inc.
465 State Route 17
Ramsey NJ 07446
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-08-10 10 $3.06 166,108 No 4 P Direct
Common Stock Acquisiton 2020-08-10 2,990 $3.07 169,098 No 4 P Direct
Common Stock Acquisiton 2020-08-10 2,000 $3.04 171,098 No 4 P Direct
Common Stock Acquisiton 2020-08-11 1,000 $2.97 172,098 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 878,444 Indirect See Footnote
Common Stock 580,957 Indirect See Footnote
Footnotes
  1. Includes 100,000 restricted stock units granted on February 28, 2020, which will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and will be settled into common stock upon vesting.
  2. These shares are owned by Areth, LLC ("Areth"). The reporting person is a control person of Areth.
  3. These shares are owned by Hariden, LLC ("Hariden"). The reporting person is the managing member of Hariden.